home / stock / dtcff / dtcff quote
Last: | $0.85608 |
---|---|
Change Percent: | 0.0% |
Open: | $0.85608 |
Close: | $0.85608 |
High: | $0.85608 |
Low: | $0.85608 |
Volume: | 1,250 |
Last Trade Date Time: | 05/02/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.85608 | $0.85608 | $0.85608 | $0.85608 | $0.85608 | 1,250 | 05-02-2024 |
$0.878 | $0.878 | $0.878 | $0.878 | $0.878 | 2,000 | 05-01-2024 |
$0.8765 | $0.9 | $0.8765 | $0.9 | $0.8584 | 5,500 | 04-25-2024 |
$0.90485 | $0.90485 | $0.90485 | $0.90485 | $0.90485 | 100 | 04-24-2024 |
$0.9623 | $0 | $0.9623 | $0 | $0 | 100 | 04-23-2024 |
$0.9623 | $0.9623 | $0.9623 | $0.9623 | $0.9623 | 500 | 04-22-2024 |
$1.05 | $1.05 | $1.05 | $1.05 | $1.05 | 211 | 04-19-2024 |
$1.04 | $1.04 | $1.04 | $1.04 | $1.04 | 104 | 04-18-2024 |
$1.08 | $0 | $1.08 | $0 | $0 | 15 | 04-16-2024 |
$1.08 | $1.08 | $1.08 | $1.08 | $1.08 | 190 | 04-11-2024 |
$1.02 | $0.99 | $1.02 | $1.02 | $0.99 | 300 | 04-10-2024 |
$1.02 | $1.02 | $1.02 | $1.02 | $1.02 | 200 | 04-09-2024 |
$1.2 | $0 | $1.2 | $0 | $0 | 1 | 04-05-2024 |
$1.2 | $1.2 | $1.2 | $1.2 | $1.2 | 1,000 | 04-04-2024 |
$1.214 | $1.2 | $1.214 | $1.214 | $1.2 | 1,000 | 04-02-2024 |
$1.25 | $1.25 | $1.25 | $1.25 | $1.25 | 300 | 03-29-2024 |
$1.25 | $1.25 | $1.25 | $1.25 | $1.25 | 300 | 03-28-2024 |
$1.224 | $1.224 | $1.224 | $1.224 | $1.224 | 100 | 03-26-2024 |
$1.2 | $1.2 | $1.2 | $1.2 | $1.2 | 100 | 03-22-2024 |
$1.26 | $1.25 | $1.26 | $1.26 | $1.25 | 1,084 | 03-21-2024 |
News, Short Squeeze, Breakout and More Instantly...
Defence Therapeutics Inc Cl A Company Name:
DTCFF Stock Symbol:
OTCMKTS Market:
Vancouver, British Columbia--(Newsfile Corp. - May 1, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC), (" Defence " or the " Company "), a Canadian biopharmaceutical company developing novel immune-oncology therapeutics and drug delivery technologies, is pleased to announce...
Vancouver, British Columbia--(Newsfile Corp. - April 23, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) (" Defence " or the " Company "), a Canadian biopharmaceutical company developing novel immune-oncology therapeutics and drug delivery technologies, is pleased to announ...
Vancouver, British Columbia--(Newsfile Corp. - April 17, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) (" Defence " or the " Company "), a Canadian biopharmaceutical company developing novel immune-oncology therapeutics and drug delivery technologies, is pleased to announ...